SCHEMBL16809405

SCHEMBL16809405

COC(=O)C(C(=O)OC)[C@@H](C[N+](=O)[O-])c1ccc2c(c1)OCO2

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.63
CYP2C19 P33261 2/20 0.63
LMNA P02545 1/20 0.61
EDNRA P25101 4/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
CYP3A4 P08684 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
MAPK1 P28482 1/20 0.46
HIF1A Q16665 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TAS1R3 Q7RTX0 5/20 0.46
TAS1R1 Q7RTX1 5/20 0.46
KMT2A Q03164 3/20 0.46
POLB P06746 1/20 0.44
SLC6A2 P23975 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7832533 0.88 ALDH1A1 (0.53) ALDH1A1CYP2C19LMNAGAAMAPT
SCHEMBL4992745 0.87 ALDH1A1 (0.49) ALDH1A1CYP2C19LMNAEDNRAGAA
SCHEMBL5376348 0.87 ALDH1A1 (0.49) ALDH1A1CYP2C19LMNAEDNRAGAA
SCHEMBL18609631 0.83 ALDH1A1 (0.63) ALDH1A1CYP2C19LMNATAS1R3TAS1R1
SCHEMBL16785346 0.83 ALDH1A1 (0.63) ALDH1A1CYP2C19LMNATAS1R3TAS1R1
SCHEMBL29434324 0.83 ALDH1A1 (0.63) ALDH1A1CYP2C19LMNATAS1R3TAS1R1
SCHEMBL4997834 0.82 ALDH1A1 (0.43) ALDH1A1CYP2C19LMNAEDNRAGAA
SCHEMBL4998200 0.80 KMT2A (0.48) ALDH1A1CYP2C19LMNAEDNRAGAA
SCHEMBL7593216 0.79 RAB9A (0.54) ALDH1A1CYP2C19LMNAEDNRAGAA
SCHEMBL7446886 0.79 RAB9A (0.49) ALDH1A1CYP2C19LMNAEDNRAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170044198-A1 TRANSITION METAL COMPLEXES FOR ENANTIOSELECTIVE CATALYSIS OF CARBON-CARBON, CARBON-HETEROATOM, AND CARBON-HYDROGEN BOND FORMING REACTIONS THE TEXAS A&M UNIVERSITY SYSTEM (US) 2017-02-16 US disclosed
US-9446393-B2 Transition metal complexes for enantioselective catalysis of carbon-carbon, carbon-heteroatom, and carbon-hydrogen bond forming reactions THE TEXAS A&M UNIVERSITY SYSTEM (US) 2016-09-20 US disclosed
US-20150165429-A1 TRANSITION METAL COMPLEXES FOR ENANTIOSELECTIVE CATALYSIS OF CARBON-CARBON, CARBON-HETEROATOM, AND CARBON-HYDROGEN BOND FORMING REACTIONS THE TEXAS A&M UNIVERSITY SYSTEM (US) 2015-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170044198-A1 TRANSITION METAL COMPLEXES FOR ENANTIOSELECTIVE CATALYSIS OF CARBON-CARBON, CARBON-HETEROATOM, AND CARBON-HYDROGEN BOND FORMING REACTIONS SOD1, C9, PYM1 ALDH1A1 1211/4885CYP2C19 1341/4885LMNA 1302/4885
US-20150165429-A1 TRANSITION METAL COMPLEXES FOR ENANTIOSELECTIVE CATALYSIS OF CARBON-CARBON, CARBON-HETEROATOM, AND CARBON-HYDROGEN BOND FORMING REACTIONS SOD1, YWHAZ, L1CAM ALDH1A1 1084/4885CYP2C19 1215/4885LMNA 1328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.